(Q44903950)
Statements
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer (English)
Wolfgang J Köstler
Günther G Steger
Afschin Soleiman
Barbara Schwab
Christian F Singer
Sandra Tomek
Thomas Brodowicz
Christoph Wiltschke
Reinhard Horvat
Raimund Jakesz
Christoph C Zielinski